Trial intelligence / Profile preview

Digoxin with Cisplatin-based Chemotherapy in Advanced HNSCC

NCT02906800Phase 2Unknown

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Jan 2017
Primary completion
May 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of digoxin in head and neck squamous cell carcinoma (HNSCC), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.

02

Drugs

digoxin
03

Conditions

head and neck squamous cell carcinoma (HNSCC)

Beyond the preview

Go deeper on NCT02906800.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02906800.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call